Header

UZH-Logo

Maintenance Infos

Pretreatment thrombocytosis: a prognostic marker for oral squamous cell carcinoma?


Kargus, Steffen; Weber, Franz E; Luebbers, Heinz T; Zemann, Wolfgang; Graetz, Klaus W; Kruse, Astrid L (2012). Pretreatment thrombocytosis: a prognostic marker for oral squamous cell carcinoma? Oral and Maxillofacial Surgery, 16(2):197-200.

Abstract

PURPOSE: Thrombocytosis associated with poorer prognoses seems to be a frequent preoperative finding in different kind of cancers. The aim of the present study was to evaluate whether thrombocytosis can be used as a prognostic marker for oral squamous cell carcinoma (SCC).
METHODS: Altogether, 288 patients with oral SCC were considered, as well as all platelet counts between 1 and 5 days prior to surgical treatment, recurrence rate, and lymph node metastasis. The minimum follow-up time was 12 months.
RESULTS: The mean preoperative thrombocyte score of the patients who received surgery was 259.55 ± 83.8 Tsd/μl; 273 out of 288 patients were in the normal thrombocyte range, and 12 had a thrombocytosis. From 51 patients with recurrence, three were in the thrombocytosis group, and 45 patients with recurrence were in the normal thrombocyte range.
CONCLUSION: The present results do not confirm that thrombocytosis can be seen as marker for poor tumor prognosis.

Abstract

PURPOSE: Thrombocytosis associated with poorer prognoses seems to be a frequent preoperative finding in different kind of cancers. The aim of the present study was to evaluate whether thrombocytosis can be used as a prognostic marker for oral squamous cell carcinoma (SCC).
METHODS: Altogether, 288 patients with oral SCC were considered, as well as all platelet counts between 1 and 5 days prior to surgical treatment, recurrence rate, and lymph node metastasis. The minimum follow-up time was 12 months.
RESULTS: The mean preoperative thrombocyte score of the patients who received surgery was 259.55 ± 83.8 Tsd/μl; 273 out of 288 patients were in the normal thrombocyte range, and 12 had a thrombocytosis. From 51 patients with recurrence, three were in the thrombocytosis group, and 45 patients with recurrence were in the normal thrombocyte range.
CONCLUSION: The present results do not confirm that thrombocytosis can be seen as marker for poor tumor prognosis.

Statistics

Citations

Dimensions.ai Metrics

Altmetrics

Downloads

40 downloads since deposited on 28 Jan 2013
15 downloads since 12 months
Detailed statistics

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > Center for Dental Medicine > Clinic of Cranio-Maxillofacial Surgery
04 Faculty of Medicine > University Hospital Zurich > Division of Surgical Research
Dewey Decimal Classification:610 Medicine & health
Scopus Subject Areas:Health Sciences > Surgery
Health Sciences > Oral Surgery
Health Sciences > Otorhinolaryngology
Language:English
Date:2012
Deposited On:28 Jan 2013 08:31
Last Modified:23 Jan 2022 23:29
Publisher:Springer
ISSN:1865-1550
OA Status:Green
Publisher DOI:https://doi.org/10.1007/s10006-011-0305-6
PubMed ID:22108700

Download

Green Open Access

Download PDF  'Pretreatment thrombocytosis: a prognostic marker for oral squamous cell carcinoma?'.
Preview
Content: Published Version
Language: English
Filetype: PDF (Nationallizenz 142-005)
Size: 183kB
View at publisher